The neurochemical effects in developing rats exposed during gestation to the 1 anticholinesterase organophosphorus insecticide chlorpyrifos (CPS) were determined. Pregnant 2 rats were dosed daily with CPS (0, 3, or 7 mg/kg) in corn oil from gestation day (GD) 6-20. Pups 3 were euthanized on postnatal days (PND) 1, 3, 6, 9, 12, and 30 for the determination of brain 4 cholinesterase (ChE) and choline acetyltransferase (ChAT) activities, along with muscarinic 5 receptor (mAChR) densities, the levels of the high affinity choline uptake (HACU) system and 6 the vesicular acetylcholine transporter (VAChT). ChE activities were inhibited about 15 and 7 30% on PND1, in the low and high dosage groups respectively, and were not different from 8 control values by PND6. mAChR densities on PND1 were reduced in the high dosage group by 9 about 18, 21, and 17%, using 3 H-N-methylscopolamine, 3 H-quinuclidinyl benzilate, and 3 H-4-10 DAMP, respectively, as ligands, and were not different from control levels by PND6. ChAT 11 activity was decreased by about 12% in the high dosage group on PND9, 12, and 30. HACU 12 levels, using 3 H-hemicholinium-3 as the ligand, were reduced by about 25% on PND6, in the 13 low and high dosage groups, and by about 14 and 21% on PND12 and 30, only in the high 14 dosage group. Levels of the VAChT were reduced by a range of 13 to 31% on PND3 through 30 15 in the high dosage group, using 3 H-AH5183 (vesamicol) as the ligand. These data suggest that 16 gestational exposure to 7 mg/kg/day CPS results in long term alterations of pre-synaptic 17 cholinergic neurochemistry. 18 19 20 Keywords: developmental neurotoxicity, chlorpyrifos, choline acetyltransferase, cholinesterase 21 inhibition, cholinergic neurochemistry, organophosphate insecticide. 22 by guest on November 7, 2016 http://toxsci.oxfordjournals.org/ Downloaded from 17
studies that have evaluated the effects of gestational exposure to CPS on the developing 12 cholinergic neurochemistry of the offspring. 13 Lassiter et al. (1998; 1999) orally exposed pregnant dams to 0, 3, 5, 7, or 10 mg/kg/day 14 from gestation day (GD) [14] [15] [16] [17] [18] and determined that fetal brain ChE was much less inhibited than 15 that of the dams on GD 18-21, and suggested that this difference was most likely the result of a 16 greater rate of protein synthesis in the developing animal. Additionally, Mattsson et al. (2000) accompanied by an 11% decrease in muscarinic acetylcholine receptor (mAChR) levels, as 1 measured by 3 H-quinuclidinyl benzilate (QNB) binding. In an additional study by Chanda and 2 Pope (1996) , dams administered 25 mg/kg/day from GD12 through GD19 resulted in about 20-3 25% brain ChE inhibition in the offspring on PND3 and a 27% decrease in mAChR levels. Qiao 4 et al. (2003) reported that subcutaneous exposure of pregnant dams to 0, 1, or 5 mg/kg/day CPS 5 administered in DMSO on GD17-20 resulted in long-term decreases, up to PND30 and 60, in the 6 levels of the high-affinity choline uptake transporter, with no corresponding effects on choline 7 acetyltransferase activity or M2/M4 mAChR levels. Recently, our laboratory reported that 8 offspring of dams orally administered 0, 3, 5, or 7 mg/kg/day from GD6 through GD20 resulted 9 in brain ChE inhibition in the offspring of about 45% on PND1 in the highest dosage group, with 10 inhibition persisting through PND9 (Richardson and Chambers, 2003) . In addition, we found a 11 13% decrease in choline acetyltransferase (ChAT) activity, the enzyme responsible for 12 acetylcholine (ACh) biosynthesis, on PND12, when ChE levels were comparable with those of 13 control animals. Therefore, it appears that while brain ChE activity in animals exposed to CPS 14 during gestation is able to recover from inhibition fairly rapidly, there may be lingering effects 15 on other neurochemical components of the cholinergic system. 16 The present study was designed to expand on the observations of our previous study 17 ( Richardson and Chambers, 2003) by the determination of the occurrence and persistence of 18 effects on the neurochemical components of the cholinergic nervous system in the offspring of 19 dams orally exposed to CPS during gestation. In addition to monitoring ChE inhibition, cell 20 surface and total mAChR levels were measured by the binding of 3 H-N-methylscopolamine 21 (NMS) and 3 H-QNB, respectively, to determine whether mAChR might be sequestered or down-22 regulated similar to that observed in animals exposed to CPS during the postnatal period (Tang /M3 and M2/M4 mAChR were determined by the   2   binding of 3 H-4-DAMP and 3 H-AF-DX 384, respectively. Furthermore, to determine whether   3 other presynaptic cholinergic markers were affected in a similar fashion as our previously 4 reported decrease in ChAT activity in rats exposed to CPS during gestation, we measured levels 5 of the high-affinity choline uptake transporter (HACU) and the vesicular acetylcholine 6 transporter (VAChT) by the binding of 3 H-hemicholinium-3 and 3 H-AH5183, respectively. The 7 results presented here confirm our previous observations of the effects of gestational exposure to 8 CPS on brain ChE and ChAT activity, and extend them by demonstrating that exposure to CPS 9 during gestation results in transient reductions of total mAChR and mAChR subtypes, but more 10 persistent reductions of HACU and VAChT levels. For breeding, rats were bred at a ratio of 3 females to 1 male. Gestational day 0 (GD0) 7 was determined by the presence of sperm in the vaginal lavage and females were housed 8 individually thereafter. Dams were randomly assigned to treatment groups, weighed daily, and 9 orally dosed from GD6-GD20 with 0, 3 (low), or 7 mg/kg/day (high) CPS in corn oil, which 10 were based upon low and high dosages used previously in our laboratory (Richardson and 11 Chambers, 2003) . Treatments were administered on a vanilla wafer (Nabisco ® ) at 0.5 ml/kg to 12 reduce handling stress involved with oral intubation. Treated cookies were totally consumed 13 within 10 min of administration. Dams were allowed to give birth and litters were culled to 10- 14 12 pups/litter on PND1 to ensure standardized nutritional availability. Pups were sampled on 15 PND1, 3, 6, 9, and 12, with an equal number of pups sampled from each litter to maintain equal 16 litter sizes, remaining pups were weaned on PND22 and euthanized on PND30, the time at 17 which the cholinergic system has reached maturity (Coyle and Yamamura, 1976 
Muscarinic Receptor Binding.
Crude synaptosomal fractions of brain (excluding 10 cerebellum and medulla-pons) were prepared using the method of Gray and Whittaker (1962), as 11 described in detail by Tang et al. (1999) . Briefly, the brain was homogenized in 10 volumes of 12 0.32 M sucrose. The homogenate was centrifuged at 1000 g for 10 min, the pellet discarded, and 13 the supernatant centrifuged at 17,000 g for 20 min. The pellet was resuspended at a 14 concentration of approximately 1 mg/ml with Krebs-Ringer buffer [comprised of (in mM): NaCl, 15 150; KCl, 5; CaCl 2 , 1.5; MgCl 2 , 1.3; HEPES, 20, pH 7.4; glucose, 10] to obtain a crude 16 synaptosomal fraction, which was kept on ice and used within 1 hr. 17 Muscarinic receptor (mAChR) levels in crude synaptosomal preparations were 18 determined with the specific ligands 3 H-NMS and 3 H-QNB using a method similar to that of were performed on all treatment groups until they returned to control levels, since data from this 19 study indicated that there were no long-term changes in QNB or NMS levels after a return to 20 control levels (data not shown). was best fit to a one-site model with a Kd of approximately 9.8 ± 0.63 nM. Therefore, binding 2 studies were conducted with a single concentration (20 nM) of 3 H-AF-DX 384 at 37 o C for 60 3 min. Specific binding was calculated as described above, and expressed as fmol/mg protein. 4 Assays were performed on all treatment groups until they returned to control levels. affinity choline uptake transporter, brain samples (whole brain without cerebellum and medulla-7 pons) were prepared as described above for M1/M3 mAChR binding, except that 50 mM glycyl-8 glycine buffer containing 200 mM NaCl and 5 mM KCl (pH 7.4) was used. 9 The binding of the high-affinity choline uptake inhibitor 3 H-HC-3 to the high-affinity 10 choline uptake transporter was measured in crude membrane preparations of the brain essentially were decreased by about 18 and 27% on PND1 and 3, respectively, only in the high dosage 9 group ( Fig. 2A) . Total mAChR levels, as measured by QNB binding, were decreased by about 10 21 and 17% on PND1 and 3, respectively, only in the high dosage group (Fig. 2B ). Levels of 11 both cell surface and total mAChR had returned to control levels by PND6. 12 M1/M3 mAChR levels, as indicated by 4-DAMP binding, were decreased by about 17 13 and 25% on PND1 in the low and high dosage groups, respectively (Fig. 3A ). On PND3, these 14 levels had returned to control values in the low dosage group. However, levels in the high dosage 15 group were decreased by about 15%, returning to control values by PND6. In contrast, M2/M4 16 mAChR levels, as indicated by AF-DX 384 binding, were not significantly different from 17 control values at any of the time points studied (Fig. 3B ). 18 ChAT activity was unaffected by treatment until PND9, where activity was decreased in 19 the high dosage group by about 11% (Fig. 4) in controls at any sampling point. Thus, it appears that exposure of dams to CPS during gestation at 7 9 mg/kg/day but not 3 mg/kg/day causes a long-term reduction of ChAT activity in the offspring.
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The high-affinity choline uptake (HACU) system develops in parallel with ChAT activity 11 (Coyle and Yamamura, 1976) and is the rate limiting step in the synthesis of ACh (Simon et al., 12 1976 ). In addition, HACU levels have been shown to be reduced by increased nerve impulse 13 activity in response to ChE inhibition (Swann and Hewitt, 1988). Therefore, we sought to 14 determine the effects of gestational exposure to CPS on the development of the HACU syststem. 15 HACU levels were significantly decreased in both the low and high dosage groups on PND6, 16 and returned to near control levels by PND9. However, starting on PND9 there was a 17 progressive decline in HACU levels in the high dosage group, which reached a maximum 18 reduction of 21% on PND30, the last day examined. A similar long-term reduction of HACU 19 levels has also been observed by Qiao et al. (2003) in the offspring of dams subcutaneously 20 exposed to 1 or 5 mg/kg/day CPS in DMSO from GD17-20. Although the study by Qiao and co-1 actions of CPS. 2 The VAChT is responsible for the transport of newly synthesized ACh into vesicles for 3 release (Parsons et al., 1993) and is present at high levels early in development, suggesting a role 4 in neural development (Aubert et al., 1996) . As with ChAT activity, VAChT levels were only 5 affected in the high dosage group, with significant decreases on PND3, 6, 9, 12, 22, and 30. In 6 addition, there appeared to be a progressive decline in VAChT levels from PND9 to PND30, in 7 the high dosage group. This is the first study, of which we are aware, that reports reductions of 8 VAChT levels in animals exposed to organophosphorus insecticides, either developmentally or 9 as adult animals. 10 The reductions observed in ChAT activity along with reductions in VAChT and HACU 11 levels suggest that pre-synaptic cholinergic neurons are especially sensitive to the effects of 12 gestational exposure to CPS at the doses used in this study. However, the mechanism behind 13 these selective decreases is not clear, since the time points demonstrating the most notable 14 effects on these markers were times at which there were no corresponding decreases in brain our neurochemical determinations were performed on whole brain without cerebellum and 11 medulla-pons, and therefore do not possess the anatomical resolution required to determine 12 whether there is specific cholinergic loss. Therefore, further study is needed to delineate the 13 mechanism responsible for the selective targeting of pre-synaptic cholinergic markers observed 14 in the high dosage group in this study. 15 In summary, repeated exposure of developing rats to CPS during gestation resulted in 16 transient decreases in ChE activity and mAChR levels, with the M1/M3 subtypes being the most 17 sensitive to exposure. In contrast to these transient effects, there were long-lasting alterations of 18 pre-synaptic components of the cholinergic system, i.e., HACU levels, ChAT activity, and 19 VAChT levels, which were still noted longer than a month after the last treatment of the dams. In 20 addition, these effects were primarily associated with time points at which there was no 21 corresponding ChE inhibition. Taken in concert, these data suggest that gestational exposure of rats to 7 mg/kg/day CPS, but not 3 mg/kg/day, results in long term alterations of pre-synaptic 1 cholinergic neurochemistry. 
